OTHERClinicalTrials.gov【Trial record】Newly listed
A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer
Phase 3RecruitingSource updated: Oct 1, 2026
What changed
Change Tracker
A factual log of movement in the official registries: records that were newly listed, revised, or closed to enrolment within the selected window. Status labels are taken directly from the registry.
125 changes since 2026-09-25
Trial records retrieved live from the ClinicalTrials.gov public API.
Last verified 2026-08-16Newly listed
Records first posted within this window
OTHERClinicalTrials.gov【Trial record】Newly listed
A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment
Phase 1Not yet recruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】Newly listed
An External Control Arm Study Comparing Survival Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With 177Lu-PSMA-617 vs Androgen Receptor Pathway Inhibitor (ARPI) Switch in Routine Care
CompletedSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Newly listed
Cardioprotection Effect of Linagliptin
Phase 3Not yet recruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】Newly listed
Immunomonitoring and Predictive Biomarkers After CAR-T Cell Therapy in B-Cell Lymphoma and Multiple Myeloma
Not applicableNot yet recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Newly listed
Mailed FIT-Based Outreach Interventions
Not applicableNot yet recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Newly listed
Radiomics for Distinguishing Benign and Malignant Lung Nodules
Not yet recruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】Newly listed
Rapid Diagnosis and Treatment Response Monitoring of Primary CNS Lymphoma Using CSF ctDNA Liquid Biopsy
RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Newly listed
SBRT for Ultra-Central NonSmall Cell Lung Cancer
Phase 1Not yet recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Newly listed
Symptoms, Physical Function, and Recovery in Patients Receiving Lung Cancer Treatment Before Surgery
Not yet recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Newly listed
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
Phase 2/3Not yet recruitingSource updated: Oct 1, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】Newly listed
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Phase 3RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Newly listed
Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans
Not applicableNot yet recruitingSource updated: Oct 1, 2026
Recently updated
Existing records whose official page was revised
USClinicalTrials.gov【Trial record】Record updated
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Phase 1RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Phase 1/2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
5HTP Regulation Of Asthma In Children
Phase 2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Phase 3RecruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Record updated
A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
Phase 1/2Not yet recruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】Record updated
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Phase 1/2RecruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Record updated
A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.
Not yet recruitingSource updated: Oct 1, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】Record updated
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2RecruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】Record updated
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Phase 2RecruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Record updated
A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
Not yet recruitingSource updated: Oct 1, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】Record updated
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Phase 1/2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
Phase 2Not yet recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Phase 2RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3RecruitingSource updated: Oct 1, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】Record updated
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Phase 2/3RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
Phase 1Active, not recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Phase 2RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia
Phase 3Active, not recruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】Record updated
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
Phase 2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Phase 1RecruitingSource updated: Oct 1, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】Record updated
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Phase 3RecruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】Record updated
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Comparative Autoantibody and Immunologic Cell Marker Study
Enrolling by invitationSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Phase 3RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
Not applicableActive, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Not applicableRecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
Phase 2RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】Record updated
Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy
RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Phase 1Not yet recruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】Record updated
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2RecruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Record updated
Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Phase 2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
Phase 1RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Phase 3RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】Record updated
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
Not applicableRecruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】Record updated
Innovative Ovarian Cancer Biomarker Assays
RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Phase 2Active, not recruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】Record updated
Linking In With Advice and Supports for Men Impacted by Metastatic Cancer
Not applicableActive, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Phase 2RecruitingSource updated: Oct 1, 2026
EUCNOTHERClinicalTrials.gov【Trial record】Record updated
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
Phase 3RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
Phase 2Not yet recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
NCI COVID-19 in Cancer Patients, NCCAPS Study
Active, not recruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】Record updated
Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab
Phase 2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Phase 3RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Phase 2RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 2/3Active, not recruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】Record updated
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
Not applicableActive, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
PET/CT Characterization of Treatment Resistance
Not applicableRecruitingSource updated: Oct 1, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】Record updated
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 3RecruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Record updated
Preliminary Assessment of [18F]BL40 in PET/CT Scans
RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】Record updated
Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
Phase 2RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial
Phase 2Active, not recruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】Record updated
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression
Phase 2RecruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】Record updated
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Not applicableRecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Phase 2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】Record updated
Roll-over Study to Allow Continued Access to Ribociclib
Phase 4Active, not recruitingSource updated: Oct 1, 2026
EUCNOTHERClinicalTrials.gov【Trial record】Record updated
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
Phase 1/2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Rutgers University Study of the Genetics of Blood Cancers
RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】Record updated
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Early Phase 1RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
Phase 2Not yet recruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】Record updated
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1Active, not recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Record updated
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】Record updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Phase 2RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】Record updated
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
Not applicableRecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
Phase 1Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Phase 1RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】Record updated
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 3Active, not recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Record updated
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
Phase 2Not yet recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】Record updated
Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
Not applicableRecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy
Not applicableActive, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】Record updated
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Phase 1RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】Record updated
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Phase 1RecruitingSource updated: Sep 30, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】Record updated
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Phase 2/3RecruitingSource updated: Sep 30, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】Record updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Phase 1/2RecruitingSource updated: Sep 30, 2026
EUClinicalTrials.gov【Trial record】Record updated
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
Phase 2Active, not recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】Record updated
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2RecruitingSource updated: Sep 30, 2026
USEUOTHERClinicalTrials.gov【Trial record】Record updated
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
Phase 2Active, not recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】Record updated
DBC-664 in Adult Patients With Solid Tumors
Phase 1RecruitingSource updated: Sep 29, 2026
No longer open
Records whose status indicates enrolment has ended
USClinicalTrials.gov【Trial record】No longer open
A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
Phase 2TerminatedSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】No longer open
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Phase 3CompletedSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】No longer open
Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
CompletedSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】No longer open
Evaluation of 3 Different Doses of IV Busulfan
Phase 2CompletedSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】No longer open
Evolution of Body Connection After Surgery
CompletedSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】No longer open
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
Not applicableCompletedSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】No longer open
Horse-assisted Interventions in an Oncological Centre
Not applicableCompletedSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】No longer open
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
Phase 1CompletedSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】No longer open
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Phase 4TerminatedSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】No longer open
Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)
Phase 1/2SuspendedSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】No longer open
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer
Not applicableCompletedSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】No longer open
Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer
Phase 1CompletedSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】No longer open
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
Phase 2CompletedSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】No longer open
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 1TerminatedSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】No longer open
Survivorship Booklets With or Without Individual Telephone Sessions in Increasing Knowledge About the Impact of Breast Cancer in African American and Latina Breast Cancer Survivors
Not applicableCompletedSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】No longer open
Timing of Rectal Cancer Resection After Preoperative Chemoradiotherapy
CompletedSource updated: Oct 1, 2026
USCNOTHERClinicalTrials.gov【Trial record】No longer open
Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma
Phase 2TerminatedSource updated: Oct 1, 2026